Krishna Yeshwant, Director, 10% Owner at Verve Therapeutics, Inc. (VERV), sold 225,310 shares at $32.32 ($5.0M) on 2022-11-03, disclosed to the SEC on 2022-11-04.
Open-market sale of $5.0M VERV by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 28,651 | $0 | 0.0% |
| 2 | $34.78 | 9,350 | $325K | 6.5% |
| 3 | $36.28 | 10,372 | $376K | 7.5% |
| 4 | $36.28 | 10,372 | $376K | 7.5% |
| 5 | $36.78 | 8,930 | $328K | 6.6% |
| 6 | $36.78 | 8,930 |
| $328K |
| 6.6% |
| 7 | $0.00 | 49,569 | $0 | 0.0% |
| 8 | $32.32 | 22,279 | $720K | 14.4% |
| 9 | $32.32 | 22,279 | $720K | 14.4% |
| 10 | $33.14 | 25,534 | $846K | 17.0% |
| 11 | $33.14 | 25,534 | $846K | 17.0% |
| 12 | $33.84 | 1,755 | $59K | 1.2% |
| 13 | $33.84 | 1,755 | $59K | 1.2% |
| Total | $22.13 avg | 225,310 | $5.0M | 100% |
| Filing → |
| VERV | SELL | 2022-11-02 | $6.5M | — | Filing → |
| FMI | SELL | 2017-08-10 | $192K | — | Filing → |
| FMI | SELL | 2017-08-08 | $1.3M | — | Filing → |